…Health (NIH). Findings from this research are said to be vital to NIAID’s efforts to advance vaccines, drugs, and diagnostic tools to better diagnose, prevent and treat infectious diseases. Cerba…

Sanofi has acquired Translate Bio as part of its endeavour to accelerate the application of mRNA to develop therapeutics and vaccines. Under the agreement, Sanofi will acquire all outstanding shares…

…effective and accepted by the medical community. The most obvious example is the mRNA technology BioNTech employed in the vaccine it developed with Pfizer. Though the technology for mRNA vaccines…

…of automation in the face of global disease. As we write this, vaccines are being injected into arms at scale and pace in many countries and we see light at…

…to existing and emerging challenges. In response to these critical threats, The Bloomsbury SET’s new Impact Connector programme will work with businesses to deliver products including vaccines, diagnostics and therapeutics…

…the focus for most Covid-19 vaccines. “A lot of research has focused on the interaction between the virus spike protein and the angiotensin-converting enzyme 2 (ACE2) for which there are…

…year in medical research. The use of animals remains an essential part of research, including in developing vaccines and treatments for Covid-19. The pharmaceutical industry remains committed to replacing, reducing…

…vaccines, to respond more quickly in potential future coronavirus pandemics. We believe that the world needs innovation to accelerate the discovery of more effective counter-measures for a range of infectious…

…vaccines and therapies. The traditional approaches once used for R&D no longer work when, for example, a scientist is trying to locate the specific mechanism of action for a drug…

…the areas of vaccines and therapy development during the pandemic would have been impossible without ongoing commitments to invest in and share new scientific techniques, and this underscores the importance…